About Us | Contact

Dr. Parvin D. Syal Investigator

NPI1831274497
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$31,097.27
from 18 payments in the last 6 years

Total Cash or Cash Equivalent

$21,936.00
from 3 payments in the last 6 years

Total In-kind Items & Services

$9,161.27
from 15 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
04/16/2021 General (Non-Research) In-kind items and services Food and Beverage $23.99 Details
Payment from Novo Nordisk Inc
Payment Record ID 810626689
03/02/2021 General (Non-Research) In-kind items and services Food and Beverage $23.73 Details
Payment from RedHill Biopharma Inc.
Payment Record ID 799948175
12/11/2020 General (Non-Research) In-kind items and services Food and Beverage $24.66 Details
Payment from Novo Nordisk Inc
Payment Record ID 745040173
10/27/2020 General (Non-Research) In-kind items and services Food and Beverage $21.23 Details
Payment from Novo Nordisk Inc
Payment Record ID 744971033
10/23/2020 General (Non-Research) In-kind items and services Food and Beverage $24.21 Details
Payment from Novo Nordisk Inc
Payment Record ID 744937335
07/31/2020 Research In-kind items and services $150.00 Details
Payment from Eli Lilly and Company
Paymment Research Study ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE
Payment Record ID 728726835
07/09/2020 Research In-kind items and services $944.50 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, PHASE 3, OPEN-LABEL TRIAL COMPARING THE EFFECT OF LY3298176 VERSUS TITRATED INSULIN DEGLUDEC ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
Clinical Trials Gov ID NCT03882970
Payment Record ID 728723161
07/21/2020 Research Cash or cash equivalent $1336.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, PHASE 3, OPEN-LABEL TRIAL COMPARING THE EFFECT OF LY3298176 VERSUS TITRATED INSULIN DEGLUDEC ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
Clinical Trials Gov ID NCT03882970
Payment Record ID 728722953
01/08/2019 Research Cash or cash equivalent Drug $12096.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03495102
Payment Record ID 654283835
12/11/2018 Research Cash or cash equivalent Drug $8504.00 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03495102
Payment Record ID 585604467
03/20/2018 Research In-kind items and services Drug $3411.30 Details
Payment from Eli Lilly and Company
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Clinical Trials Gov ID NCT03495102
Payment Record ID 585604465
06/26/2018 Research In-kind items and services $3365.54 Details
Payment from Eli Lilly and Company
Paymment Research Study ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE
Payment Record ID 585604463
03/09/2018 General (Non-Research) In-kind items and services Travel and Lodging $277.57 Details
Payment from Eli Lilly and Company
Payment Record ID 559613091
03/09/2018 General (Non-Research) In-kind items and services Travel and Lodging $225.00 Details
Payment from Eli Lilly and Company
Payment Record ID 559613089
03/09/2018 General (Non-Research) In-kind items and services Food and Beverage $325.91 Details
Payment from Eli Lilly and Company
Payment Record ID 559613087
03/07/2018 General (Non-Research) In-kind items and services Travel and Lodging $307.99 Details
Payment from Eli Lilly and Company
Payment Record ID 559613085
11/22/2017 General (Non-Research) In-kind items and services Food and Beverage $19.27 Details
Payment from PFIZER INC.
Payment Record ID 503044349
10/23/2017 General (Non-Research) In-kind items and services Food and Beverage $16.37 Details
Payment from PFIZER INC.
Payment Record ID 502907529
;